New pharmaceutical composition comprising an oligonucleotide that is adapted to target nucleic acids encoding CD40, useful for preventing or treating an inflammatory, immune or autoimmune disorder

摘要

A pharmaceutical composition comprising an oligonucleotide that is adapted to target nucleic acids encoding CD40, thus modulating the expression of CD40 mammalian cells, and an amphoteric liposome as an excipient, is new. ACTIVITY : Immunosuppressive; Dermatological; Antiinflammatory; Antiarthritic; Anti-thyroid; Gastrointestinal. No biological data given. MECHANISM OF ACTION : Immunotherapy.